Portfolio company
Tourmaline Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops antibody therapeutics for patients with immune and inflammatory conditions, including atherosclerotic cardiovascular disease and thyroid eye disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Viridiantherapeutics
This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.
Yarrow Bioscience
This biotechnology company develops monoclonal antibody therapies for patients with autoimmune thyroid conditions, including Graves' disease and thyroid eye disease.
Ethyreal Bio
This company develops monoclonal antibodies to treat Graves' disease and thyroid eye disease for patients with these autoimmune conditions.
Granite Bio
This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.
Boulevard Bio
This clinical-stage biotechnology company develops multi-specific antibody therapies for patients suffering from B cell-driven autoimmune diseases.
Cabaletta Bio
This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Vor Bio
This biotechnology company develops therapies for patients living with serious autoantibody-driven autoimmune diseases, such as myasthenia gravis and Sjögren's disease.
